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Abstract 
The last decade has seen an increase in the application of graphene oxide (GO) in the 
biomedical field. GO has been successfully exploited for its ability to deliver many kinds of 
drugs into target cells. However, GO toxicity assessment is still controversial. Several 
studies demonstrated that GO protein coating is crucial to alleviate the material’s toxicity. 
Besides, coronation leads to the formation of big agglomerates, reducing the cellular 
uptake of the material and thus its therapeutic efficiency. In this work, we propose a simple 
and efficient method based on rapid (Ultra-Turrax, UT) mixing to control protein corona 
formation. Using UT protocol, we were able to reduce GO agglomeration in the presence 
of proteins and to obtain stable GO dispersions in cell culture media. By labelling GO with 
luminescent nanoparticles (QDs), we studied the GO internalization kinetic and efficiency. 
Comparing the “classic” and the UT protocols, we found that the latter allows a faster and 
more efficient internalization both in macrophages and HeLa cells without affecting cell 
viability. We believe that the use of UT protocol will be interesting and suitable for the 
preparation of next generation GO-based drug delivery platforms. 
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1. Introduction 
The last decade has seen a remarkable growth of carbon nanomaterial applications in the 
biomedical field.1 In particular, the graphene family nanomaterials are promising to tear 
down the current limits in the biomedical fields by proposing innovative solutions for bio-
detection, tissue engineering, and drug and gene delivery.2 For the latter application, 
graphene oxide has certainly become the most studied nanomaterial. GO is produced by 
the exfoliation process of graphite under strong oxidative conditions. Chemically speaking, 
GO is composed by a single-layer of carbon (like graphene) where 40 to 60% of the C 
atoms are bound to oxygen. The oxidation process enriches the nanosheets with different 
highly polar oxygen functional groups (i.e. epoxides, alcohols and carboxylic acids) that 
render GO extremely stable in water and in many other polar solvents.3 Moreover, GO 
production have been standardized with treatments to ensure low contamination risks 
(organic and inorganic), tailored size and high reproducibility.2 Several studies have 
demonstrated the ability of GO to penetrate cell membranes and release small drugs, 
genetic materials, or macromolecules.2,4 Additionally, GO can be functionalized with 
different molecules such as dispersants, imaging agents, targeting and therapeutic 
molecules, making this material a perfect platform for theragnostic and multimodal 
applications.2,4 
However, several issues still need to be addressed. Currently, application of GO in the 
biomedical field is ruled by the dichotomy between efficiency of the treatment (in vivo or in 
vitro) and the GO toxicity. Before any GO-based therapy reaches the clinical stage, the 
evaluation of risks over benefits must be carefully analyzed. Regarding the risks, it has 
been observed that concentration, size, exposure method and time strongly affect the GO 
toxicity, often leading to controversial results.5 A crucial step in understanding and 
eventually modulating the GO toxicity is related to its interaction with proteins.6 Indeed, 
each GO sheet is able to stably load a huge amount (from 2 to 12 times its weight) of 
proteins onto its surface.7,8 This interaction strongly depends on protein structure and is 
due to a mixture of different contributions.7,8 Non-covalent interactions are driven by 
enthalpy with a main contribution of low polar interactions happening between C sp2 
aromatic domains and the lipophilic residues.9 Besides, covalent reactions can also occur 
on GO surface. In the latter case, radical addition10,11 and epoxide nucleophilic ring 
opening are the most probable reactions that could happen between serum proteins and 
GO sheets. Despite the unclear GO-protein coronation, it is known that this process is very 
short (5-10 minutes) and strongly alters the protein secondary structure.8 In particular, it 
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has been observed that the interaction with GO leads to the conversion of a-helix into b-
sheet, causing the subsequent agglomeration into the cell culture media.8 Interaction with 
proteins must therefore be carefully evaluated for the preparation of GO in drug delivery 
applications. Indeed, the formation of covalent or non-covalent protein corona on the 
nanostructures irreversibly alters their dispersibility, cell uptake and most importantly the 
pharmacokinetics and pharmacodynamics.5 Most of the drug administration pathways 
involve local or intravenous injection, where the nanocarriers immediately encounter 
plasmatic proteins leading to the corona formation. Different studies demonstrated that GO 
cytotoxicity can be alleviated by the first interaction with serum proteins.6,11,12 The corona 
formation can mitigate the material cytotoxicity but it can also affect the colloidal stability of 
the formulation, due to the formation of large agglomerates and consequently slowing 
down or reducing the cell uptake.5 Although numerous in vitro toxicity studies using GO-
based materials have been performed, to date these studies have not resulted in the 
creation of a standardized protocol applicable to many of the new candidates under 
development for biomedical applications. 
In this work we propose a method to control the corona formation by reducing the degree 
of flake agglomeration. This is achieved by premixing the GO with the serum proteins 
using Ultra-Turrax (UT), a disperser based on the rotor-stator technology able to disperse 
the material via a high circumferential speed. We compared the UT technique with the 
“classic” mixing of the material with the biological media. Aiming to follow the nanomaterial 
uptake, we prepared GO functionalized with luminescent nanocrystals. We used HeLa 
cells, as both nonphagocytic epithelial and cancer cell model, and Raw 264.7 
macrophages as immune and phagocytic cell model. These two cell lines represent two 
important models for general in vitro evaluation of cytotoxicity of nanomaterials for 
biomedical applications. By comparing the two methods, we found that the UT allows the 
preparation of a dispersion with smaller GO agglomerates and higher colloidal stability. 
This allows us to increase the speed and quantity of the GO taken up into both cell lines. 
In addition, the UT treatment improves cell viability in Raw 264.7 macrophages incubated 
with the functionalized GO, suggesting that this could be a crucial step in the safety 
studies of GO-based formulations for drug delivery. 
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2. Experimental 
2.1 Materials 
Graphene oxide was synthesized following the modified method by Prof. Nishina13 and 
obtained as an aqueous dispersion at 3 mg/ml concentration. All the chemicals were 
purchased from Sigma Aldrich. The solvents were obtained from commercial suppliers and 
used without purification. Water was purified using a Millipore filter system MilliQ® and free 
endotoxin Polisseur Biopak®. When stated, suspensions were sonicated in a water bath 
(20 W, 40 kHz).  
 
2.2 Instruments 
TEM analysis were carried out with Hitachi 7500 transmission electron microscope (Hitachi 
High Technologies Corporation, Tokyo, Japan) equipped with an AMT Hamamatsu digital 
camera (Hamamatsu Photonics, Hamamatsu City, Japan). Fluorescence steady state 
spectra were recorded via Fluorolog FL3-22 (HORIBA JobinYvon) using swig xenon 450 
W lamp. Lifetime measurements were recorded using light-emitting diodes (NanoLED) 
exciting at 460 nm at a fixed emission of 710 nm. The GO-QD and QDs were analyzed at 
10 µg/ml concentration. For the dispersion Ultra-Turrax (IKA) t10 was used.  
XPS analyses were performed on a Thermo Scientific K-Alpha X-ray photoelectron 
spectrometer with a basic chamber pressure of 10-8-10-9 bar with an anode using Al Kα 
radiation (hn = 1486.6 eV). The samples were analyzed as a powder. Spots size of 400 
µm were used. The survey spectra are average of 10 scans with a pass energy of 200.00 
eV and a step size of 1 eV. An ion gun was turned on during analysis. For each sample 
the analysis was repeated three times. 
Confocal images have been carried out with a Microscope Zeiss Axio Observer Z1 
Confocal Spinning disk equipped with 63 or 100 X oil objective. Z-staking was recorded 
with 0.3 µm interplanar distance. The fluorescence signal from Cell-Mask was obtained 
using 488 nm laser excitation and recording in the green channel (505-555 nm) while GO-
QD, was recorded with using 488 nm laser excitation, in the far-red channel (665-715 nm). 
Images have been then treated with FIJI software. 
 
2.3 Methods 
ZnS-doped AgInS2 synthesis 
InCl3 (88.4 mg, 0.4 mmol) was added to AgNO3 (17 mg, 0.1 mmol) in a 100 ml round 
bottom flask. Subsequently, 190 µl of oleic acid (0.6 mmol), 720 µl of dodecylthiol (3 mmol) 
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and 8 ml of octadecene were added under vigorous stirring (420 rpm). The dispersion was 
flushed with argon for 15 min. Subsequently the temperature was risen and kept at 60°C 
for 15 min, then at 95 °C for 15 min, and 110°C for other 15 min until dissolution of indium 
and silver salts. After, 9.6 mg (0.3 mmol) of S dissolved in 4 ml of oleylamine were rapidly 
added with a syringe. Immediately, the solution turned from pale pink to dark pink. After 15 
min, 70.5 mg (0.5 mmol) of ZnCl2 dissolved in 3 ml of oleylamine and 2 ml of 1-octadecene 
were added and the temperature was increased to 150 °C and kept for other 15 min. 
Then, the reaction was chilled with an ice bath and the crude compound was washed by 6 
cycles of washing three times using ethanol and three times using acetone as anti-solvent. 
Finally, the QDs were dispersed in 20 ml of CH2Cl2 and stored at 4 °C (concentration 2 
mg/ml). Concentration was calculated evaporating and weighing the solid of a known 
volume of solution.  
 
Preparation of GO-QDs 
One mg of QDs was dispersed in 1 mg of CH2Cl2 in a 20 ml vial. Subsequently, 1 ml of GO 
dispersion (1 mg/ml in milliQ water) was slowly added with a micropipette allowing the 2-
phase formation. The vial was capped with a plastic cap pierced with a syringe needle. 
The dispersion was left under agitation overnight. During this period, the organic phase 
was completely evaporated. The crude complex was first centrifuged at 1000 rpm for 5 min 
to remove unreacted QDs. Subsequently, the supernatant was centrifuged at 13000 rpm 
for 10 min and the pellet was re-dispersed in fresh water three times. Control reaction of 
unreacted GO was also carried out. The supernatant of control GO and GO-QD was 
analyzed by a spectrophotometer UV-vis (abs 300 nm). In case of control reaction, most of 
the GO remain in the supernatant meanwhile, GO-QD supernatant does not show any 
appreciable GO signal indicating that the reaction is quantitative for GO. For these reasons 
we assumed that all the GO has reacted with the QDs. GO-QD was stored at a 
concentration of 1 mg GO/ml in milliQ water in the dark at 4 °C. All the biological 
experiments have been performed using the same concentration of GO, either pure or in 
the complex with QDs. 
 
2.4 Cell culture  
HeLa (epithelial, human cervical adenocarcinoma) and Raw 264.7 (macrophages, Abelson 
murine leukaemia virus-induced tumour) cells were cultured as mono-layers in Dulbecco’s 
modified Eagle medium supplemented with 10 µg/mL gentamycin (Lonza BioWhittaker), 
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10 mM HEPES (Lonza BioWhittaker), 0.05 mM β-mercaptoethanol (Lonza BioWhittaker) 
and 10 % FBS, in a humidified incubator (37 °C, 5% CO2). For toxicity experiments, cells 
were seeded in 24-well plates (approximately 0.5x105 cells/cm2, 1 mL/well). The 
nanomaterials were diluted in the cell culture media at different concentrations and 
subsequently cells were exposed for 24 h to the treatments. For confocal microscopy, the 
cells were seeded in 8-well chamber slide (Thermo Scientific) (approximately 1x104 
cells/cm2, 500 µl/well). Cells were left to grow until 70-80 % confluency and exposed up to 
24 h to the nanomaterials.  
 
2.5 Cytotoxicity assay 
Cell viability was determined by flow cytometry using the standard assay with FVD 
(Fixable Viability Dyes, violet, Invitrogen), 24 h after exposure to the materials. The 
supernatant was aspirated and discarded and the cells were washed twice with PBS. Cells 
were detached from the plates using a scraper in the case of Raw 264.7 and for HeLa was 
used a solution of 0.25% Trypsin/0.53 mM EDTA. The cells were washed with PBS, 2 % 
foetal bovine serum and then were incubated (20 min, 4 °C) with the dye (dil. 1: 2000). 
Thereafter, the cells were washed with PBS, 2 % foetal bovine serum and resuspended in 
300 µl and immediately acquired on the cytometer (Beckman Coulter, Fullerton, CA, USA). 
At least 10 000 cells were counted for each sample, and experiments were performed in 
triplicate. 
 
2.6 Data analysis and statistical methods 
Flow cytometry data were generated using FlowJo software (FlowJo LLC, Ashland, OR, 
USA) and saved as .LMD files. The files were analyzed by FlowJo software version 7.6.5. 
Cell viability (%) was calculated as [(A)/(B) × 100], where A and B are the number of live 
cells on treated and control groups, respectively. Values represent mean ± SD (n = 3). 
 
2.7 Preparation of biological dispersions 
An aliquot of solution corresponding at 1 mg of GO (GO-QD) was centrifuged for 30 min at 
13 000 rpm. Subsequently, the pellet was re-dispersed in 1.8 ml of DMEM serum free cell 
media under sterile condition. For “classic” method, 200 µl (10% total volume) of FBS was 
added dropwise under stirring. For UT method, the GO dispersion was mixed using Ultra-
Turrax at 10000 rpm (1-2 min), while 200 µl of FBS (10% total volume) were added 
dropwise within 1 to 2 minutes. 
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3. Results and discussions 
3.1 Material Preparation 
To investigate and validate a new protocol for the preparation of GO dispersions in cell 
culture medium, we used a material with a size of 600 ± 300 nm. Fluorescent GO (GO-
QD) was prepared via functionalization with ZnS doped AgInS2 nanocrystals (QDs) with a 
size of 5 nm (Figure 1a). The QDs have been synthetized according to the literature14 
using oleylamine as the capping agent. Tuning the Zn doping temperature (150 °C), we 
successfully prepared Far-Red (FR) luminescent nanocrystals with photoluminescence 
(PL) centered at 720 nm (Figure 1b).  
  
 
Figure 1. Morphological and photophysical characterization of GO-QD: TEM image of (a) as-
prepared QDs (Scale bar: 100 nm); (b) emission spectra of QDs in CHCl3 and GO-QD in water at 
10 µg/ml (lex 480 nm); (c) TEM image of GO-QD (scale bar: 500 nm) [inset: magnification showing 
QDs onto the GO surface (scale bar 100 nm)]; (d) lifetime characterization of QDs and GO-QD in 
CH2Cl2 and water, respectively. QD dispersion in water was impossible due to their high 
hydrophobicity; (e) optical image of GO-QD at 10 µg/ml under light and UV lamp. 
 
The complexation of GO with the hydrophobic QDs was performed via simple 
adsorption.15 The GO-QD was obtained through various washing cycles to remove 
unreacted QDs from the media. Subsequently, the GO-QD was stored in water at 4 °C in 
the dark to avoid possible quenching due to photobleaching. TEM analysis (Figure 1c) 
displayed that the QDs are clearly adsorbed onto the GO surface.  In addition, the XPS 
characterization of GO and QDs are in good agreement with the literature (Figure S1).13,14 
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XPS spectrum of GO-QD further supports the coexistence of both GO and QD phases. In 
addition, functionalization with QD does not alter the size and lateral dimensions of the GO 
sheets (Figure S2). Steady state fluorescence characterization showed that the GO-QD 
has an emission centered at 720 nm (Figure 1b). Lifetime analysis of the QDs in CH2Cl2 
revealed two main contributions: a long emission (818 ns, 59%) attributed to donor-
acceptor transition between two localized states inside of the lattice structure and a short 
emission (334 ns, 41%) attributed to a surface trap state recombination (Figure 1d).16 
When QDs are anchored to GO, a sensible decrease of both long (175 ns, 64%) and short 
(33 ns, 36%) contributions was measured. This reduction can be attributed to an energy 
transfer (ET) process between the QDs and the GO.17 The ET is enhanced by the 
proximity of the GO to the QDs’ donor states and it affects more the luminescence coming 
from the surface defects of the QDs. Additionally, we investigated the stability of the GO-
QD adduct after one month aging in water (4 °C). TEM characterization shows that the 
QDs remain adsorbed onto the GO surface (Figure S3). Lifetime characterization of the 
aged sample evidenced a negligible change in the lifetime (Figure 1d). This long shelf-life 
together with the bright luminescence visible to the eye, even at low concentrations (Figure 
1e), make the GO-QD an interesting material for bioimaging experiments. 
Both GO and GO-QD tend to form micrometric aggregates as mixed into the complete cell 
culture media. Stable dispersions can be obtained by mixing the GO or GO-QD with the 
serum-free cell culture media, but as the serum is added (at a final concentration of 10% 
for optimal cell culture conditions) the GO immediately starts to flocculate and it 
precipitates after 4 h. Similar results have been obtained when fetal bovine serum (FBS) 
was added under vigorous magnetic stirring. As discussed above, the formation of protein 
corona involves a covalent and non-covalent interaction between the GO and the proteins. 
Furthermore, this process happens very quickly and is completed in a 5-10 min time 
scale.8 Each protein can react or be adsorbed onto more than one GO sheet, causing the 
formation of large agglomerates. Considering the fast kinetic of the corona formation, we 
assumed that the mixing conditions are the key variable to control the agglomeration. The 
magnetic stirrer often does not go over 900 rpm agitation speed and may be not enough 
for the GO and protein fast diffusion in solution. For this reason, we enhanced the stirring 
conditions using a UT disperser. We decided to set up the UT speed at 10 000 rpm to 
allow an intensive stirring but without inducing damage to the GO or GO-QD flakes (Figure 
S4). Agglomerate formation has been evaluated by TEM microscopy and the results are 
shown in Figure 2. 
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Figure 2. Preparation of GO for in vitro experiments using the classic (C) or UT protocol in the 
presence of 10% FBS: (a) Schematic representation of the preparation of GO C. (b) TEM 
micrographs of GO C in cell culture media. Scale bar: 2 µm. (c) Optical image of GO C after 4 h of 
incubation. (d) Schematic representation of the preparation of GO UT. (e) TEM micrographs of GO 
UT in cell culture media. Scale bar: 2 µm. (f) Optical image of GO UT after 4 h of incubation. 
 
Classic (C) treatment of GO showed the formation of big agglomerates after contact with 
FBS (Figure 2b), with sizes larger than 5 µm. Meanwhile UT treatment for GO displayed a 
significant decrease of the size of the agglomerates (Figure 2e). This microscopic effect is 
in agreement with the colloidal stability of the formulations where GO, under classic 
conditions, leads to a sedimentation after 4 h (Figure 2c), while the GO prepared via UT 
has an improved stability and a slower sedimentation (Figure 2f). The mechanism of 
interaction of GO with proteins in cell culture media is complex and difficult to investigate. 
As mentioned before, different studies pointed out the fact that GO can adsorb/react with 
proteins within 5 to 10 minutes with a high yield (from 2 to 12 times its weight).7,8 However, 
all these studies were generally accomplished using only one protein. FBS is a mixture of 
elements containing, among others, proteins, amino acids and salts. It is this complexity of 
elements in the cell culture media that render the elucidation of the exact mechanism of 
interaction of GO with all the nutrients difficult. Besides, agglomeration of GO is observed 
when it comes in contact with FBS and this is mainly via an interaction with proteins.18 The 
mechanism of this coronation is mostly the result of a mixture of π-π interactions and 
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epoxide opening reactions. π-π interactions occur between hydrophobic domains of the 
proteins and GO, while epoxide opening reactions happen between the epoxide groups of 
GO and the free amino groups of the protein amino acids. If we focus on GO and protein 
macrostructures, we can fairly say that each entity possesses more than one active site 
and so can undergo multiple reactions. Moreover, these active sites react very quickly. GO 
and proteins are large structures characterized by slow diffusion coefficients, hence the 
mixing conditions are critical. Therefore, diffusion and coronation rates are crucial for the 
preparation of a uniform and stable dispersion. It is probable that under “classical” 
conditions the process of coronation is faster than the GO and proteins’ diffusion 
velocities. In this case, multiple protein/GO reactions are most likely to happen, leading to 
the formation of inhomogeneous supramolecular structures composed of multiple sheets 
and proteins (Figure 2b and c). Instead, the UT, rotating at a speed of 10000 rpm, is able 
to significantly accelerate the GO and protein diffusion rates, fast enough to compete with 
the complexation/functionalization rate and thus inducing the formation of a stable and 
homogeneous dispersion (Figure 2e and f). 
 
3.2 In vitro experiments 
Interaction of GO with the different cell lines was then evaluated using live cell confocal 
microscopy, which avoids artifacts due to cell fixation. For this purpose, we incubated the 
cells with GO and GO-QD prepared via “classic” (termed GO C and GO-QD C) or Ultra-
Turrax mixing (termed GO UT and GO-QD UT). The cells were incubated with the material 
at 5 and 20 µg/ml. Sedimentation of the material on top of the cells or in empty spaces of 
the well can be easily visualized by transmission microscopy after incubation with each 
material at 20 µg/ml after 4, 8 and 24 h (Figure 3). 
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Figure 3. Bright field images of Raw 264.7 (upper panels) and HeLa (lower panels) cells 
after 24 h of incubation at 20 µg/ml with the different materials. Scale bar: 10 µm. 
 
By comparing with the control images (Figure 3, first column from the left), where there is 
no material at the bottom of the well or on the surface of the cells, we were able to observe 
how the GO C started its sedimentation at 4 h and increased it over time (Figure S5). After 
24 h (Figure 3, second column from the left), the GO C sediment has created on both cell 
lines a thick layer of material that uniformly covers the cell surface and the extracellular 
space. The same pattern can be observed for GO-QD C (Figure 3, fourth column from the 
left). In this case the material appears to be thicker, probably due to the high optical 
density of the QDs on the GO surface. 
When the GO is pretreated with UT, the material sedimentation is significantly reduced. 
Only a few agglomerates were observed after 24 h in both Raw 264.7 and HeLa cells 
(Figure 3, third column from the left). GO-QD UT showed a similar behavior (Figure 3, last 
column). As already reported by Vranic et al.,10 GO C dispersed into cell culture media 
deposits rapidly on top of the cells forming a thick layer of material. The treatment with UT 
is instead able to clearly reduce the material agglomeration (Figure 2b and e) and 
consequently its sedimentation, improving the colloidal stability in the cell culture media. 
Subsequently, we were interested in whether the UT treatment was able to influence or 
modify the uptake and the internalization kinetic of the material compared with the 
classical method. The internalization was evaluated at a GO-QD concentration of 5 µg/ml 
at different time points (4, 8 and 24 h). We used this low concentration to avoid a thick 
layer of material on top of the cells that would have made the analysis and interpretation of 
the results more difficult. 
The macrophages treated with the material prepared via the “classic” method showed a 
low efficiency in the internalization of the material after 24 h (Figure 4). It is noteworthy to 
mention that, from the z-stacking analysis, a very low signal was detected inside the cells, 
while most of the GO-QD C seems stuck in the cell membrane. By 8 h, the UT treatment 
already allowed the internalization of the material, with a clear localization of the GO-QD 
UT passing through the cell membrane. 
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Figure 4. Z-stacking analysis with xz and yz orthogonal views on live Raw 264.7 cells incubated 
with 5 µg/ml of GO-QD C (upper panel) and UT (lower panel) after 4, 8 and 24 h. In green, 
membranes stained with Cell-Mask; in red, GO-QDs. Scale bar: 10 µm. 
 
An analogous pattern was also observed in HeLa cells (Figure 5). GO-QD C uptake was 
seen after 24 h of incubation, while in the case of the UT treated sample the material was 
already internalized after 8 h of incubation. The uptake efficiency was estimated 
comparing HeLa and Raw 264.7 cells after incubation with 20 µg/ml of GO-QD after 24 h. 
In this experiment, we compared the signal coming from different cell height levels by 
visualizing the plane on top of the cell (external material) and the plane in the middle 
(internalized material) (Figure S6).  
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Figure 5. Z-stacking analysis with xz and yz orthogonal views on live HeLa cells incubated with 5 
µg/ml of GO-QD C (upper panel) and UT (lower panel) after 4, 8 and 24 h. In green, membranes 
stained with Cell-Mask; in red, GO-QD. Scale bar: 10 µm. 
 
GO-QD prepared with the “classic” procedure is localized mostly on top of Raw 264.7 and 
HeLa cells (Figure 6). The analysis of the middle planes showed that a small amount of 
material is inside the cells, while most of the GO-QD C is localized on the cell surface or in 
the extracellular space. In the case of GO-QD UT, only a few aggregates were detected on 
top of the cells (Figure 6), while a significant accumulation of the GO-QD UT was observed 
inside cell membranes. Similar results were obtained with HeLa cells. This remarkable 
difference in uptake efficiency can also be appreciated in Video S1 and Video S2 (GO-QD 
C and GO-QD UT) for Raw 264.7 cells and in Video S3 and Video S4 (GO-QD C and GO-
QD UT) for HeLa cell lines. 
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Figure 6. Interaction of GO-QD with Raw 264.7(left panel) and Hela (right panel) cells. 
Comparison between the surface height top level of the cells (TOP columns) and the middle height 
level (MIDDLE columns). In green, membranes stained with Cell-Mask; in red, GO-QD. Scale bar: 
10 µm. 
 
The full assessment of this protocol consisted also on the study of the cytotoxic effect of 
GO-based materials on the cells treated in the different conditions.  
In vitro toxicological characterization of the GO and GO-QD prepared by both methods 
was evaluated through the degree of cell survival by flow cytometry using the standard 
assay with violet Fixable Viability Dye (FVD). The analysis of cytotoxicity after incubation in 
HeLa cells with the nanomaterials showed that viability was not significantly reduced by 
the presence of the GO or GO-QD up to 100 μg/ml concentration after 24 h of treatment 
(Figure 7a, b). In the case of Raw 264.7 the viability is significantly reduced to 40% for the 
cells treated with GO at the highest concentrations. Regarding the GO preparation 
method, we did not observe highly significant viability differences except at the lowest 
concentration (5 μg/ml). In this latter case, GO prepared by ultra-mixing could be used to 
satisfactory achieve adequate intracellular concentrations of the material while avoiding 
significant cell damage.  
In the case of GO-QD, the material obtained with the UT method improved the viability up 
to 80-100% compared to the control, while with the classic method we obtained similar 
results to GO. These data are in agreement with different studies where cell viability 
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decreases by 20% after exposure to GO concentrations around 10 μg/ml during 24 h or 
longer.19 
 
 
Figure 7. Evaluation of cell viability by flow cytometry using the standard assay with violet 
FVD. (a, b) HeLa cells. (c, d) Raw 264.7 cells. Cells were treated with the nanomaterials 
prepared by both methods (C and UT) for 24 h. Data represent means ± SD (n = 3). * (in 
black) shows statistically significance compared with the control. * (in red) shows 
statistically significance comparing the method used in the preparation of the nanomaterial 
(Two-way ANOVA followed by Bonferroni’s post-test: ns p>0.05, *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001). 
 
To analyze how the GO and GO-QD affect cell viability, we need to consider how the cells 
“see” the nanomaterials depending on their own characteristics. The differences between 
the composition of the cell membrane in HeLa and Raw 264.7 cells, including their uptake 
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mechanisms and translocation, will influence the nanomaterial’s fate in the intracellular 
environment, since transport greatly depends on the composition of cellular membranes. It 
is likely that the toxicity may be induced by the interaction of the nanomaterials with cells’ 
membranes in Raw 264.7 (i.e., professional phagocytes). This hypothesis is also 
corroborated by the FVD standard assay, where the reactive dye can permeate the 
damaged membranes of dead cells and covalently attaches to the interior and exterior 
amines of the proteins. This result highlights the importance of evaluating nano-safety by 
using different cellular systems. The observed sensitivity of Raw 264.7 macrophages, 
among other immune cells, compared with epithelial cell lines has been described in the 
design of comprehensive strategies in in vitro toxicity testing of a panel of representative 
oxide nanomaterials.20  
Furthermore, the physic-chemical characteristics of the nanomaterials, like composition, 
size, dispersibility and how they interact with the biological components of the medium in 
which they are dispersed, also influences the cytotoxicity. As a result of the coronation 
process of the material with the proteins of the cell culture medium, its composition, which 
is essential for cell nutrition, can be significantly changed leading to non-optimal cell 
culture conditions for a cell line. 
Size, shape and agglomeration of the nanomaterials have been also found to greatly 
influence their cellular uptake. In our case, classic mixing and UT mixing could play an 
important role in the speed, quantity and mechanism of the nanomaterials taken up by 
macrophages and HeLa cells. They might aggregate into many different shapes and sizes 
that make it hard to dictate the outcome and interpretation of the results regarding 
internalization mechanisms. By only analyzing the aggregate’s size, the internalization 
pathway change.21,22 In addition, it has been shown how coronation is able to sensibly 
affect the cytotoxicity and the uptake mechanism.6,22 A preliminary evidence about the 
possible internalization mechanism by RAW 264.7 can be inferred from Figure S7. In the 
case of GO-QD C the material appears trapped into the cell membranes (Figure S7a and 
b), while UT treatment shows the internalization by formation of membrane protrusions, 
allowing the uptake of the material likely via macropinocytosis, a mechanism characteristic 
of this type of phagocytic cells (Figure S7c-e). GO-QD UT are also clearly visible inside 
endocytic vesicles (Figure S7f-i). For aggregates in the range of a few hundred 
nanometers, the predictable behavior would be clathrin-mediated endocytosis, while 
aggregates > 1 µm are trapped into large fluid pockets by formation and enclosure of 
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membrane protrusions.21 Our results correlate with the data already reported in the 
literature.22 
Toxicity of nanomaterials and in particular the graphene family is a complex field.23 Unlike 
soluble drugs, where concentration and exposure time are the most important parameters, 
graphene oxide guidelines for toxicity regards also shape,24 size,25,26 surface 
functionalization27,28 and number of layers.29,30 For instance, we have already 
demonstrated how GO size, oxidation degree and functionalization play an important role 
in the denaturation of siRNA.31 Moreover, the general toxicity depends on the cell and 
animal models used, where in some cases it can be harmful2 and in others it can induce 
genotoxicity25 and/ or long term side effects.32 Considering this information, the answer to 
the toxicity of GO or GO-QD is not straightforward and would require more study including 
in vivo tests. The aim of this study was to describe and propose a new general protocol to 
obtain well-dispersed GO samples in cell culture media for cell imaging and tracking. In 
this context, we would like to underline the importance of producing colloidal stable 
nanomaterial dispersions. Highly polydisperse formulations would certainly lead to less 
predictive and irreproducible results due to the intrinsic inhomogeneity of the systems. The 
novelty of the proposed protocol is certainly the mild mixing conditions, which does not 
involve the use of any surfactant or stabilizers. Therefore, it can virtually be applied to all 
GO formulations and can be used as standard for the new generation of graphene-based 
drug delivery systems. 
 
4. Conclusions 
In conclusion, our results using the UT confirm the importance of assuring high 
dispersibility during protein corona formation in the preparation of a nanomaterial for 
biomedical applications. Smaller aggregates and a more homogeneous protein corona 
contribute not only to improve colloidal stability of the formulation but also to mitigate 
cytotoxicity and change the biological responses to the material in terms of cellular uptake 
and translocation. We believe that the standardization of the UT method in the preparation 
of GO-based materials for biological applications will be of great interest to the nano-safety 
and nano-pharmaceutical scientific community to improve cell viability and uptake 
efficiency of GO-based materials. 
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